• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

富血小板血浆提取分析:4种常见商用试剂盒之间血小板和血液成分的差异

Analysis of Platelet-Rich Plasma Extraction: Variations in Platelet and Blood Components Between 4 Common Commercial Kits.

作者信息

Fitzpatrick Jane, Bulsara Max K, McCrory Paul Robert, Richardson Martin D, Zheng Ming Hao

机构信息

School of Surgery, The University of Western Australia, Crawley, Western Australia, Australia.; QEII Medical Centre, Nedlands, Western Australia, Australia.

Chair in Biostatistics, Institute for Health Research, University of Notre Dame, Fremantle, Western Australia, Australia.

出版信息

Orthop J Sports Med. 2017 Jan 3;5(1):2325967116675272. doi: 10.1177/2325967116675272. eCollection 2017 Jan.

DOI:10.1177/2325967116675272
PMID:28210651
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5302100/
Abstract

BACKGROUND

Platelet-rich plasma (PRP) has been extensively used as a treatment in tissue healing in tendinopathy, muscle injury, and osteoarthritis. However, there is variation in methods of extraction, and this produces different types of PRP.

PURPOSE

To determine the composition of PRP obtained from 4 commercial separation kits, which would allow assessment of current classification systems used in cross-study comparisons.

STUDY DESIGN

Controlled laboratory study.

METHODS

Three normal adults each donated 181 mL of whole blood, some of which served as a control and the remainder of which was processed through 4 PRP separation kits: GPS III (Biomet Biologics), Smart-Prep2 (Harvest Terumo), Magellan (Arteriocyte Medical Systems), and ACP (Device Technologies). The resultant PRP was tested for platelet count, red blood cell count, and white blood cell count, including differential in a commercial pathology laboratory. Glucose and pH measurements were obtained from a blood gas autoanalyzer machine.

RESULTS

Three kits taking samples from the "buffy coat layer" were found to have greater concentrations of platelets (3-6 times baseline), while 1 kit taking samples from plasma was found to have platelet concentrations of only 1.5 times baseline. The same 3 kits produced an increased concentration of white blood cells (3-6 times baseline); these consisted of neutrophils, leukocytes, and monocytes. This represents high concentrations of platelets and white blood cells. A small drop in pH was thought to relate to the citrate used in the sample preparation. Interestingly, an unexpected increase in glucose concentrations, with 3 to 6 times greater than baseline levels, was found in all samples.

CONCLUSION

This study reveals the variation of blood components, including platelets, red blood cells, leukocytes, pH, and glucose in PRP extractions. The high concentrations of cells are important, as the white blood cell count in PRP samples has frequently been ignored, being considered insignificant. The lack of standardization of PRP preparation for clinical use has contributed at least in part to the varying clinical efficacy in PRP use.

CLINICAL RELEVANCE

The variation of platelet and other blood component concentrations between commercial PRP kits may affect clinical treatment outcomes. There is a need for standardization of PRP for clinical use.

摘要

背景

富血小板血浆(PRP)已被广泛用于治疗肌腱病、肌肉损伤和骨关节炎中的组织愈合。然而,提取方法存在差异,这导致产生不同类型的PRP。

目的

确定从4种商业分离试剂盒中获得的PRP的成分,这将有助于评估交叉研究比较中使用的当前分类系统。

研究设计

对照实验室研究。

方法

三名正常成年人每人捐献181毫升全血,其中一些用作对照,其余的通过4种PRP分离试剂盒进行处理:GPS III(Biomet Biologics)、Smart-Prep2(Harvest Terumo)、麦哲伦(Arteriocyte Medical Systems)和ACP(Device Technologies)。所得PRP在商业病理实验室进行血小板计数、红细胞计数和白细胞计数检测,包括分类计数。葡萄糖和pH值测量通过血气自动分析仪获得。

结果

发现从“血沉棕黄层”取样的3种试剂盒的血小板浓度更高(为基线的3至6倍)而从血浆取样的1种试剂盒的血小板浓度仅为基线的1.5倍。同样的3种试剂盒产生的白细胞浓度增加(为基线的3至6倍);这些白细胞包括中性粒细胞、白细胞和单核细胞。这代表了高浓度的血小板和白细胞。pH值略有下降被认为与样品制备中使用的柠檬酸盐有关。有趣的是,在所有样品中均发现葡萄糖浓度意外升高,比基线水平高3至6倍。

结论

本研究揭示了PRP提取中血液成分(包括血小板、红细胞、白细胞、pH值和葡萄糖)的差异。细胞的高浓度很重要,因为PRP样本中的白细胞计数经常被忽视,被认为无关紧要。临床使用的PRP制备缺乏标准化至少部分导致了PRP使用中临床疗效的差异。

临床意义

商业PRP试剂盒之间血小板和其他血液成分浓度的差异可能会影响临床治疗结果。临床使用的PRP需要标准化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7798/5302100/b44244e36ac4/10.1177_2325967116675272-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7798/5302100/7af2343bbd61/10.1177_2325967116675272-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7798/5302100/72869520662c/10.1177_2325967116675272-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7798/5302100/f8c6c2cc0387/10.1177_2325967116675272-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7798/5302100/b113ccd75886/10.1177_2325967116675272-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7798/5302100/6e4ed139e283/10.1177_2325967116675272-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7798/5302100/c957047e2cb2/10.1177_2325967116675272-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7798/5302100/b44244e36ac4/10.1177_2325967116675272-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7798/5302100/7af2343bbd61/10.1177_2325967116675272-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7798/5302100/72869520662c/10.1177_2325967116675272-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7798/5302100/f8c6c2cc0387/10.1177_2325967116675272-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7798/5302100/b113ccd75886/10.1177_2325967116675272-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7798/5302100/6e4ed139e283/10.1177_2325967116675272-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7798/5302100/c957047e2cb2/10.1177_2325967116675272-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7798/5302100/b44244e36ac4/10.1177_2325967116675272-fig7.jpg

相似文献

1
Analysis of Platelet-Rich Plasma Extraction: Variations in Platelet and Blood Components Between 4 Common Commercial Kits.富血小板血浆提取分析:4种常见商用试剂盒之间血小板和血液成分的差异
Orthop J Sports Med. 2017 Jan 3;5(1):2325967116675272. doi: 10.1177/2325967116675272. eCollection 2017 Jan.
2
Matrix metalloproteinase content and activity in low-platelet, low-leukocyte and high-platelet, high-leukocyte platelet rich plasma (PRP) and the biologic response to PRP by human ligament fibroblasts.低血小板、低白细胞和高血小板、高白细胞富血小板血浆(PRP)中的基质金属蛋白酶含量和活性,以及人韧带成纤维细胞对 PRP 的生物学反应。
Am J Sports Med. 2014 May;42(5):1211-8. doi: 10.1177/0363546514524710. Epub 2014 Mar 13.
3
Characterization and comparison of 5 platelet-rich plasma preparations in a single-donor model.在单供体模型中对 5 种富血小板血浆制剂的特性和比较。
Arthroscopy. 2014 May;30(5):629-38. doi: 10.1016/j.arthro.2014.02.020.
4
Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma.生长因子和分解代谢细胞因子的浓度受富含血小板血浆的细胞成分的影响。
Am J Sports Med. 2011 Oct;39(10):2135-40. doi: 10.1177/0363546511417792. Epub 2011 Aug 16.
5
Comparison of the Cellular Composition and Cytokine-Release Kinetics of Various Platelet-Rich Plasma Preparations.不同富血小板血浆制剂的细胞组成和细胞因子释放动力学比较。
Am J Sports Med. 2015 Dec;43(12):3062-70. doi: 10.1177/0363546515608481. Epub 2015 Oct 15.
6
Commercial Separation Systems Designed for Preparation of Platelet-Rich Plasma Yield Differences in Cellular Composition.用于制备富血小板血浆的商业分离系统在细胞组成上产生产量差异。
HSS J. 2017 Feb;13(1):75-80. doi: 10.1007/s11420-016-9519-3. Epub 2016 Aug 19.
7
Cellular Components and Growth Factor Content of Platelet-Rich Plasma With a Customizable Commercial System.一种可定制商业系统的富含血小板血浆的细胞成分和生长因子含量。
Am J Sports Med. 2019 Apr;47(5):1216-1222. doi: 10.1177/0363546519827947. Epub 2019 Mar 8.
8
Concentrations of Blood Components in Commercial Platelet-Rich Plasma Separation Systems: A Review of the Literature.商用富血小板血浆分离系统中血液成分浓度:文献综述。
Am J Sports Med. 2019 Feb;47(2):479-487. doi: 10.1177/0363546517746112. Epub 2018 Jan 16.
9
Harmful Effects of Leukocyte-Rich Platelet-Rich Plasma on Rabbit Tendon Stem Cells In Vitro.富含白细胞的富血小板血浆对兔肌腱干细胞的体外有害作用。
Am J Sports Med. 2016 Aug;44(8):1941-51. doi: 10.1177/0363546516644718. Epub 2016 May 16.
10
Commercial blood cell separation systems versus tube centrifugation methods for the preparation of platelet-rich plasma: a preliminary cross-sectional study.商用血细胞分离系统与管离心法制备富血小板血浆的比较:一项初步的横断面研究。
Rev Assoc Med Bras (1992). 2021 Apr;67(4):536-541. doi: 10.1590/1806-9282.20200989.

引用本文的文献

1
An evaluation of a low-cost platelet-rich plasma for osteoarthritis of the knee: A pilot study.一项关于低成本富血小板血浆治疗膝骨关节炎的评估:一项初步研究。
J Exp Orthop. 2025 Sep 5;12(3):e70420. doi: 10.1002/jeo2.70420. eCollection 2025 Jul.
2
The Concept of Anatomical Reconstruction of the Foveola Using Activated Conditioned Plasma (ACP).使用活化条件血浆(ACP)进行黄斑中心小凹解剖重建的概念。
J Clin Med. 2025 Jul 29;14(15):5358. doi: 10.3390/jcm14155358.
3
Efficacy of Combined Use of PELNAC and Platelet-rich Plasma in Promoting Wound Healing.

本文引用的文献

1
The Effectiveness of Platelet-Rich Plasma in the Treatment of Tendinopathy: A Meta-analysis of Randomized Controlled Clinical Trials.富血小板血浆治疗肌腱病的有效性:随机对照临床试验的荟萃分析
Am J Sports Med. 2017 Jan;45(1):226-233. doi: 10.1177/0363546516643716. Epub 2016 Jul 21.
2
Comparison of the Cellular Composition and Cytokine-Release Kinetics of Various Platelet-Rich Plasma Preparations.不同富血小板血浆制剂的细胞组成和细胞因子释放动力学比较。
Am J Sports Med. 2015 Dec;43(12):3062-70. doi: 10.1177/0363546515608481. Epub 2015 Oct 15.
3
Efficacy of Intra-articular Platelet-Rich Plasma Injections in Knee Osteoarthritis: A Systematic Review.
PELNAC与富血小板血浆联合使用促进伤口愈合的疗效
Plast Reconstr Surg Glob Open. 2025 Aug 6;13(8):e7062. doi: 10.1097/GOX.0000000000007062. eCollection 2025 Aug.
4
Limitations to clinically restoring meaningful peripheral nerve function across gaps and overcoming them.临床修复跨越间隙的有意义的周围神经功能的局限性以及克服这些局限性的方法。
Exp Biol Med (Maywood). 2025 May 27;250:10566. doi: 10.3389/ebm.2025.10566. eCollection 2025.
5
Advances in sciatic nerve regeneration: A review of contemporary techniques.坐骨神经再生的进展:当代技术综述
Regen Ther. 2025 May 6;29:563-574. doi: 10.1016/j.reth.2025.04.016. eCollection 2025 Jun.
6
Inflammatory Signatures and Biological Markers in Platelet-Rich Plasma Therapy for Hair Regrowth: A Comprehensive Narrative Analysis.富血小板血浆疗法促进头发生长中的炎症特征和生物标志物:一项全面的叙述性分析。
Diagnostics (Basel). 2025 Apr 28;15(9):1123. doi: 10.3390/diagnostics15091123.
7
Indications and contraindications to platelet-rich plasma injections in musculoskeletal diseases in case of infectious, oncological and haematological comorbidities: A 2025 formal consensus from the GRIIP (International Research Group on Platelet Injections).在存在感染、肿瘤和血液系统合并症的情况下,富血小板血浆注射治疗肌肉骨骼疾病的适应症和禁忌症:来自GRIIP(国际血小板注射研究组)的2025年正式共识
Knee Surg Sports Traumatol Arthrosc. 2025 Jun;33(6):2293-2306. doi: 10.1002/ksa.12682. Epub 2025 Apr 22.
8
The Regenerative Marriage Between High-Density Platelet-Rich Plasma and Adipose Tissue.高密度富血小板血浆与脂肪组织的再生联姻。
Int J Mol Sci. 2025 Feb 27;26(5):2154. doi: 10.3390/ijms26052154.
9
Safety and efficacy of platelet-rich plasma injections in basal thumb osteoarthritis; should we offer it or not?富血小板血浆注射治疗拇指基底节骨关节炎的安全性和有效性;我们是否应该采用这种治疗方法?
J Hand Microsurg. 2025 Feb 8;17(3):100223. doi: 10.1016/j.jham.2025.100223. eCollection 2025 May.
10
Assessing Standardisation in Platelet-Rich Plasma (PRP) Injections for the Management of Greater Trochanteric Pain Syndrome (GTPS): A Systematic Review of the Available Literature.评估富血小板血浆(PRP)注射治疗大转子疼痛综合征(GTPS)的标准化:现有文献的系统评价
Cureus. 2024 Nov 28;16(11):e74690. doi: 10.7759/cureus.74690. eCollection 2024 Nov.
关节腔内注射富血小板血浆治疗膝骨关节炎的疗效:一项系统评价
Arthroscopy. 2016 Mar;32(3):495-505. doi: 10.1016/j.arthro.2015.08.005. Epub 2015 Oct 1.
4
Effect of Leukocyte Concentration on the Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis.白细胞浓度对富血小板血浆治疗膝骨关节炎疗效的影响
Am J Sports Med. 2016 Mar;44(3):792-800. doi: 10.1177/0363546515580787. Epub 2015 Apr 29.
5
Platelet-rich plasma in tendon models: a systematic review of basic science literature.富含血小板的血浆在肌腱模型中的应用:基础科学文献的系统评价。
Arthroscopy. 2013 Mar;29(3):596-607. doi: 10.1016/j.arthro.2012.10.025. Epub 2013 Jan 24.
6
Treatment of lateral epicondylitis with platelet-rich plasma, glucocorticoid, or saline: a randomized, double-blind, placebo-controlled trial.富血小板血浆、糖皮质激素或生理盐水治疗外侧肱骨上髁炎:一项随机、双盲、安慰剂对照试验。
Am J Sports Med. 2013 Mar;41(3):625-35. doi: 10.1177/0363546512472975. Epub 2013 Jan 17.
7
Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy.优化富含血小板血浆中的白细胞浓度治疗腱病。
J Bone Joint Surg Am. 2012 Oct 3;94(19):e143(1-8). doi: 10.2106/JBJS.L.00019.
8
Platelet-rich plasma: the PAW classification system.富血小板血浆:PAW 分类系统。
Arthroscopy. 2012 Jul;28(7):998-1009. doi: 10.1016/j.arthro.2012.04.148.
9
Platelet-rich plasma for calcific tendinitis of the shoulder: a case report.富血小板血浆治疗肩部钙化性肌腱炎:一例报告
J Orthop Surg (Hong Kong). 2012 Apr;20(1):126-30. doi: 10.1177/230949901202000128.
10
Pain and activity levels before and after platelet-rich plasma injection treatment of patellar tendinopathy: a prospective cohort study and the influence of previous treatments.富血小板血浆注射治疗髌腱病前后的疼痛和活动水平:一项前瞻性队列研究及既往治疗的影响。
Int Orthop. 2012 Sep;36(9):1941-6. doi: 10.1007/s00264-012-1540-7. Epub 2012 Apr 27.